Streetbeat News

Products Services

CSTL

Castle Biosciences has presented new data demonstrating the ability of its DecisionDx-SCC test to identify cutaneous squamous cell carcinoma tumors at a biologically high risk of metastasis.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 11:10 am

ATNM

Actinium Pharmaceuticals announced Sierra trial results for Iomab-B in treating relapsed/refractory acute myeloid leukemia at the European Hematology Association 2023 Congress. The company expects to file a BLA for Iomab-B by the end of 2023.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 11:06 am

MULN

Mullen Technologies announced the development of a light-weight electric vehicle (EV) truck body in collaboration with Phenix Truck Bodies & Van Equipment of Southern California. The partnership aims to create a more efficient and environmentally friendly truck body for the EV market.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 11:05 am

ALVO

JNJ

TEVA

Alvotech and Teva have secured a US license date for AVT04, a proposed biosimilar to Stelara, and reached a settlement and license agreement with Johnson & Johnson concerning AVT04.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 11:04 am

MRKR

Marker Therapeutics announced the treatment of the first lymphoma patient with MT-601 in a Phase 1 clinical trial. This marks a significant milestone for the company's T cell therapy program.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 11:04 am

KDNY

ORCL

XPEV

Several stocks recorded gains in today's pre-market trading session, including Chinook Therapeutics, which jumped 66.8% after agreeing to be acquired by Novartis AG. XPeng's shares climbed 9.6% following strong pre-sale orders for its new SUV, the G6. Other notable gainers include Braskem, Paramount Global, Olo Inc., Kingsoft Cloud Holdings, Archer Aviation, Amprius Technologies, Intellia Therapeutics, NIO, and Oracle Corporation.

Portfolio Pulse from Lisa Levin

June 12, 2023 | 10:55 am

XPEV

XPeng announced that it has received over 25,000 pre-sale orders in China for its G6 SUV within three days, causing its shares to trade higher.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 10:48 am

KALV

Kalvista Pharmaceuticals presented data on Sebetralstat for Hereditary Angioedema, supporting the globalization of the KONFIDENT Phase 3 trial and its use in short-term prophylaxis.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 10:37 am

BRTX

BioRestorative Therapies announced that clinical data for its BRTX-100 treatment is expected to be reviewed by an independent data safety monitoring board (DSMB) for initial safety dosing profile.

Portfolio Pulse from Benzinga Newsdesk

June 12, 2023 | 10:30 am

XPEV

XPeng Inc has received over 25,000 pre-sale orders in China for its G6 SUV within three days. The vehicle, which debuted in April, has a maximum range of 755km and can charge 300km in 10 minutes. XPeng reported a 45.9% YoY sales decline in Q1 FY23.

Portfolio Pulse from Anan Ashraf

June 12, 2023 | 10:30 am